Skip to main content
. 2022 Autumn;13(4):772–779. doi: 10.22088/cjim.13.4.772

Table 5.

Frequency of MMR-deficiency in endometrioid endometrial cancer in various status

Possibility of LS*
(%)
MMR-deficient
N (%)
Clinical scenario
7.65 8/17 (47) FH of cancer (+)
3.1 14/74 (19) FH of cancer (-)
11.4 7/10 (70) FH of LS-associated cancer (+)
3 15/81 (18.5) FH of LS-associated cancer (-)
3.94 22/91 (24.2) Total

*LS: Lynch Syndrome